Nobre, Ana Rita http://orcid.org/0000-0002-5509-904X
Dalla, Erica
Yang, Jihong http://orcid.org/0000-0002-2753-0939
Huang, Xin http://orcid.org/0000-0001-6778-8849
Wullkopf, Lena
Risson, Emma
Razghandi, Pedram
Anton, Melisa Lopez
Zheng, Wei
Seoane, Jose A. http://orcid.org/0000-0002-3856-9177
Curtis, Christina
Kenigsberg, Ephraim
Wang, Jianlong http://orcid.org/0000-0002-1317-6457
Aguirre-Ghiso, Julio A. http://orcid.org/0000-0002-6694-6507
Funding for this research was provided by:
Ministry of Education and Science | Fundação para a Ciência e a Tecnologia (SFRH/BD/100380/2014)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (T32 CA078207, CA109182, CA216248, CA218024, CA196521)
JY received no specific funding for this work.
XH received no specific funding for this work.
Bundesministerium für Bildung und Forschung (431474090)
ER received no specific funding for this work.
PR received no specific funding for this work.
MJA received no specific funding for this work.
WZ received no specific funding for this work.
JS received no specific funding for this work.
CC received no specific funding for this work.
EK received no specific funding for this work.
New York State Stem Cell Science (C32569GG, C32583GG)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM129157)
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD095938, R01HD097268)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL146664)
Samuel Waxman Cancer Research Foundation
Article History
Received: 9 April 2022
Accepted: 13 July 2022
First Online: 1 September 2022
Competing interests
: J.A.A.-G. is a scientific co-founder of scientific advisory board member and equity owner in HiberCell and receives financial compensation as a consultant for HiberCell, a Mount Sinai spin-off company focused on the research and development of therapeutics that prevent or delay the recurrence of cancer. The remaining authors declare no competing interests.